124,000 New Cancers In Europe Due to Obesity

ECCO/ESMO UPDATE — BERLIN 2009

Being overweight was a key reason for at least 124,000 new cancers in European countries in 2008, including nearly 24,000 from colorectal cancer.

3.2 percent of new cancer diagnoses in men and 8.8 percent of women’s cancers could be attributed to excessive body mass index (BMI).  This was a dramatic increase from  2002 that found 70,000 cases of cancer directly related to obesity out of 2.2 million European cancers overall. Continue reading…

Posted by Kate Murphy on September 30th, 2009
Posted in: Research & Treatment News | No Comments »
Tags: colorectal cancer prevention, obesity

Colorectal Cancer News in Brief: September 25

Briefly: Randomized research found that radiation treatment to the entire brain after surgery for tumors that had spread to the brain didn’t improve either survival or the time that patients remained able to function independently.  Mice with muscle wasting and fat loss from cancer benefited from a commonly used diabetes drug.

In other headlines, Katie Couric received an award from Fordham University and called her work with colorectal cancer awareness “her greatest achievement.”  A panel at the FDA has recommended approval of a new formulation of OxyContin that is less easy to tamper with. Online registration for the October 4th Strides for Life Walk/Run closes on October 1. Continue reading…

Posted by Kate Murphy on September 25th, 2009
Posted in: Research & Treatment News | No Comments »
Tags: brain metastases, cachexia, Katie Couric, OxyContin, Strides for Life

Aspirin Prevents Lynch Syndrome Cancers

ECCO/ESMO UPDATE — BERLIN 2009

Although initial reports found no reduction in polyps or cancer in people with Lynch syndrome who took aspirin and/or resistant starch supplements, longer follow-up tells a difference story.

About five years after trial participants began taking aspirin or a placebo, differences began to emerge. Even though patients in the trial only took aspirin for four years, later followup found significantly fewer colon colon cancers among those who had used  aspirin, as well as fewer Lynch-related cancers overall.   There were almost three times as many colon cancers in Lynch carriers who took a placebo compared to those who used aspirin. Continue reading…

Posted by Kate Murphy on September 24th, 2009
Posted in: Research & Treatment News | No Comments »
Tags: aspirin, colorectal cancer prevention, Lynch syndrome

Judi Sohn in the Cloud

C3 Vice President for Operations, Judi Sohn, explains how cloud computing has helped C3 grow successfully over a short time in a new video included in the Convio e-newsletter going to thousands of people.

She also manages to let those many readers know about C3′s mission and work, as she explains how keeping our heads in the online clouds has saved money while drawing together staff and volunteers from across the country to win the fight against colorectal cancer. Continue reading…

Posted by Kate Murphy on September 23rd, 2009
Posted in: C3 News | No Comments »

C3 Joins Kaleidoscope Celebration

C3 is excited to be a partner in Kaleidoscope – a holiday entertainment special featuring Olympic skating champions and GRAMMY Award-winning music artists while addressing issues surrounding women and cancer.

The show will air nationally on FOX on Thanksgiving Day, November 26, 2009 from 4:00 – 5:30pm EST  immediately following the Thanksgiving football telecast.

Presented with the support of sanofi-aventis, the show will be highlighted by the historic return of legendary Scott Hamilton and Dorothy Hamill who will skate to the music of fellow cancer survivor Olivia Newton-John and music producer David Foster.   Continue reading…

Posted by Kate Murphy on September 23rd, 2009
Posted in: C3 News | No Comments »